VC-Backed Heat Biologics Gets Debt Financing from Square 1
December 18, 2012
Square 1 Bank, a commercial banking partner to entrepreneurs and the venture capital world, has provided a debt facility to VC-backed Heat Biologics, a clinical-stage immunotherapy company. Heat's ImPACT (Immune Pan-Antigen Cytotoxic Therapy) therapeutics vaccines are aimed at a number of cancers and infectious diseases, with the hope of providing an off-the-shelf therapy for patients with both early and advanced stages of cancer. Existing investors include Seed-One Ventures, Brightline Ventures and The University of Miami. Square 1's VC branch serves the financial needs of the VC community in all stages of growth and expansion.